Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

DRAQ5-based DNA content analysis of hematolymphoid cell subpopulations discriminated by surface antigens and light scatter properties.

Yuan CM, Douglas-Nikitin VK, Ahrens KP, Luchetta GR, Braylan RC, Yang L.

Cytometry B Clin Cytom. 2004 Mar;58(1):47-52.

2.

Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.

Bergeron RJ, Weimar WR, Luchetta G, Sninsky CA, Wiegand J.

Drug Metab Dispos. 1996 Mar;24(3):334-43.

PMID:
8820425
3.

Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.

Bergeron RJ, Weimar WR, Luchetta G, Streiff RR, Wiegand J, Perrin J, Schreier KM, Porter C, Yao GW, Dimova H.

Drug Metab Dispos. 1995 Oct;23(10):1117-25.

PMID:
8654201
4.

The role of charge in polyamine analogue recognition.

Bergeron RJ, McManis JS, Weimar WR, Schreier KM, Gao F, Wu Q, Ortiz-Ocasio J, Luchetta GR, Porter C, Vinson JR.

J Med Chem. 1995 Jun 23;38(13):2278-85.

PMID:
7608892
5.

Antiproliferative properties of polyamine analogues: a structure-activity study.

Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JR, Kramer D, et al.

J Med Chem. 1994 Oct 14;37(21):3464-76.

PMID:
7932575
6.

A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.

Bergeron RJ, Streiff RR, Creary EA, Daniels RD Jr, King W, Luchetta G, Wiegand J, Moerker T, Peter HH.

Blood. 1993 Apr 15;81(8):2166-73.

7.

A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.

Bergeron RJ, Streiff RR, Wiegand J, Luchetta G, Creary EA, Peter HH.

Blood. 1992 Apr 1;79(7):1882-90.

8.

A comparative evaluation of iron clearance models.

Bergeron RJ, Streiff RR, Wiegand J, Vinson JR, Luchetta G, Evans KM, Peter H, Jenny HB.

Ann N Y Acad Sci. 1990;612:378-93.

PMID:
2127168

Supplemental Content

Loading ...
Support Center